Register for our free email digests:
People
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Haruvi Takes Charge Of Sandoz North America
Novartis has appointed its former global head of M&A, Keren Haruvi, to take over from Carol Lynch as president of Sandoz US and head of North America.
Who’s Hired? IGBA Names IPA’s Jain As Chair
The International Generic and Biosimilar Medicines Association has named the IPA’s Sudarshan Jain as its new chair. While Celltrion’s chairman has stepped down, Coherus has added two members to its board of directors and Synthon has appointed a new CEO.
Who’s Hired? Pfenex’ Lucy Joins Lykan Bioscience
Pfenex founder and chief business officer Patrick Lucy has left the company to join Lykan Bioscience. Meanwhile, Samsung Biologics has announced the appointment of a new president and CEO, as the Australian generics and biosimilars association appoints a new chair.
AAM Reiterates Sustainability Challenge As Biden Nominates Becerra
With incoming US President Joe Biden designating a new Secretary of Health and Human Services, the US Association for Accessible Medicines has underlined the challenges threatening the sustainability of the generics and biosimilar industry.
Who’s Hired? Apotex Names New US President & CEO
As Apotex names its new US president and CEO, Akorn puts together a fresh board of directors following bankruptcy proceedings. Stada has made new appointments in Germany, while Siegfried makes significant changes in its leadership roles.
Who’s Hired? Four Firms Focus On Finance
A flurry of financial appointments has been seen across the off-patent industry, involving major players Dr Reddy’s, Biocon, Mayne Pharma and Xbrane Biopharma.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.